Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
The Performance of Machine Learning for Prediction of H3k27 M Mutation in Midline Gliomas: A Systematic Review and Meta-Analysis Publisher



Habibi MA1 ; Aghaei F2 ; Tajabadi Z3 ; Mirjani MS2 ; Minaee P2 ; Eazi S2
Authors
Show Affiliations
Authors Affiliations
  1. 1. Department of Neurosurgery, Shariati Hospital, Tehran University of Medical Science, Tehran, Iran
  2. 2. Student Research Committee, Faculty of Medicine, Qom University of Medical Sciences, Qom, Iran
  3. 3. Digestive Disease Research Institute, Shariati Hospital, Tehran University of Medical Science, Tehran, Iran

Source: World Neurosurgery Published:2024


Abstract

Background: Diffuse midline gliomas (DMGs) encompass a set of tumors, and those tumors with H3K27 M mutation carry a poor prognosis. In recent years, machine learning (ML)-based radiomics have shown promising results in predicting gene mutation status non-invasively. Therefore, this study aims to comprehensively evaluate the diagnostic performance of ML-based magnetic resonance imaging radiomics in predicting H3K27 M mutation status in DMG patients. Methods: A systematic search was conducted using relevant keywords in PubMed/Medline, Scopus, Embase, and Web of Science from inception to May 2023. Original studies evaluating the diagnostic performance of ML models in predicting H3K27 M mutation status in DMGs were enrolled. Quality assessment of the enrolled studies was conducted using QUADAS-2. Data were analyzed using STATA version 17.0 to calculate pooled sensitivity, specificity, positive and negative likelihood ratio, diagnostic score, and diagnostic odds ratio. Results: A total of 13 studies, including 12 retrospectives and 1 both retrospective and prospective study, enrolled 1510 (male = 777) DMG patients. Six studies underwent meta-analysis which showed a pooled sensitivity, specificity, positive and negative likelihood ratio, diagnostic score, and diagnostic odds ratio of 0.91 (95% CI 0.77–0.97), 0.81 (95% CI 0.73–0.88), 4.86 (95% CI 3.25–7.24), 0.11 (95% CI 0.04–0.29), 3.75 (95% CI 2.62–4.88), and 42.61 (95% CI 13.77–131.87), respectively. Conclusions: Non-invasive prediction of H3K27 M mutation status in patients with DMGs using magnetic resonance imaging radiomics is a promising tool with good diagnostic performance. However, the pooled metrics had a wide confidence interval, which required further studies to enhance ML algorithms' accuracy and facilitate their integration into daily clinical practice. © 2023 Elsevier Inc.
Experts (# of related papers)